肾臟医疗器材和服务市场 - 全球产业规模、份额、趋势、机会与预测，按产品、应用、地区和竞争细分，2020-2030 年预测

2024 年全球肾臟医疗设备和服务市场价值为 159 亿美元，预计在整个预测期内将稳步增长，到 2030 年的年复合成长率(CAGR) 为 5.15%。这些设备在肾臟病学（肾臟的研究）中至关重要，并用于各种医疗保健环境，包括医院、诊所和家庭护理。该市场涵盖了广泛的技术，包括超音波机器、CT 扫描仪和 MRI 机器等影像设备，用于诊断肿瘤、囊肿和肾结石等肾臟相关疾病。慢性肾病 (CKD) 和终末期肾病 (ESRD) 等肾臟疾病盛行率的上升是推动市场成长的主要因素。促成因素包括人口老化、糖尿病、高血压以及与生活方式相关的健康问题，这些因素扩大了需要肾臟医疗设备和服务的患者群体。

市场概况
预测期	2026-2030
2024 年市场规模	159亿美元
2030 年市场规模	215.4 亿美元
2025-2030 年复合年增长率	5.15％
成长最快的领域	透析设备
最大的市场	北美洲

*关键市场驱动因素**

*慢性肾病 (CKD) 和末期肾病 (ESRD) 盛行率不断上升**

CKD 和 ESRD 发生率的不断上升是全球肾臟医疗设备和服务市场扩张的主要驱动力。随着全球肾臟疾病发病率的上升，对治疗、设备和服务的需求持续成长。全球约有 7 亿人患有 CKD，如果考虑到急性肾损伤 (AKI) 和肾衰竭的额外负担，这一数字将上升至约 8.5 亿，影响到世界人口的 10% 以上。由于缺乏广泛的早期检测和筛检计划，这一数字可能被低估。 CKD 发展为 ESRD 需要持续的医疗干预，主要是透析和相关治疗。随着越来越多的患者患上 ESRD，对透析机、肾臟监测器、过滤系统和其他必需肾臟设备的需求也随之增加，从而推动市场成长。此外，糖尿病、高血压和肥胖等危险因子的盛行率不断上升，进一步增加了全球肾臟疾病的负担，凸显了对有效管理策略的迫切需求。糖尿病是肾臟疾病的主要原因，而高血压和糖尿病合计占新发肾衰竭病例的三分之二。

*主要的市场挑战**

*经济不确定性**

经济不稳定会影响市场的各个方面，包括购买决策、医疗保健预算以及对医疗设备和服务的投资。在经济不确定时期，医院和诊所等医疗机构可能会面临预算限制，导致资本支出受到限制。因此，对肾臟医疗设备和服务的投资可能会被延迟。由于医疗保健机构寻求更具成本效益的解决方案，经济挑战也会对医疗器材製造商和服务提供者施加价格压力，这可能会影响利润率。此外，经济不确定性可能会减少研发计画的资金，从而阻碍肾臟医疗设备的创新。市场的波动，特别是股票价格和投资者信心的波动，也可能受到经济状况的影响，患者的行为也可能受到影响，有些人选择推迟选择性手术或探索成本较低的替代方案。

*主要市场趋势**

*居家血液透析**

居家血液透析越来越受欢迎，它使患有 ESRD 的患者能够在自己舒适的家中接受透析治疗。许多患者更喜欢这种选择，因为它提供了更大的灵活性，可以适应他们的个人日程安排。这种以患者为中心的方法刺激了对居家血液透析设备和服务的需求。接受居家透析的患者由于能够更频繁地或更长时间来进行透析，因此可以获得更好的临床结果。此外，居家血液透析消除了频繁前往医疗机构的需要，减轻了患者及其家人的负担。它还可以降低医疗环境中常见的感染风险。从成本角度来看，家庭血液透析透过减少与机构照护相关的费用，提供了更实惠的替代方案。製造商正在开发更用户友好且紧凑的机器，以方便家庭治疗，而远距医疗和远端监控技术使医疗保健提供者能够管理患者的进展并根据需要调整治疗，从而提高安全性和有效性。

*主要市场参与者**

雅培实验室公司

B Braun Melsungen AG

百特国际公司

碧迪公司

波士顿科学公司

DaVita 医疗保健合作伙伴公司

费森尤斯集团

资讯咨询公司

美敦力公司

尼普洛公司

*市场区隔**

全球肾臟医疗设备与服务市场细分如下：

**按产品：**

透析设备

肾臟去神经支配装置

穿戴式人工肾臟装置

远端栓塞保护装置

**按应用：**

肾衰竭

慢性肾臟病 (CKD)

末期肾病 (ESRD)

肾结石疾病

高血压

糖尿病

其他的

**按地区：**

北美（美国、加拿大、墨西哥）

亚太地区（中国、印度、韩国、澳洲、日本）

欧洲（德国、法国、英国、西班牙、义大利）

南美洲（巴西、阿根廷、哥伦比亚）

中东和非洲（南非、沙乌地阿拉伯、阿联酋）

*竞争格局**

市场竞争格局包括对全球肾臟医疗设备和服务市场主要公司的详细分析。

*可自订**

该报告可以根据公司的具体需求进行客製化。 TechSci Research 提供客製化服务，例如纳入其他市场参与者（最多五家）的详细公司简介。

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：顾客之声

第五章：肾臟医疗设备与服务市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 副产品（透析设备、肾臟去神经支配装置、穿戴式人工肾臟装置、远端栓塞保护装置）
  • 应用（肾衰竭、慢性肾臟病、末期肾病、肾结石疾病、高血压、糖尿病、其他）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第 6 章：北美肾臟医疗设备与服务市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 加拿大
  • 墨西哥

第七章：欧洲肾臟医疗设备与服务市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 英国
  • 义大利
  • 法国
  • 西班牙

第 8 章：亚太肾臟医疗设备与服务市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美洲肾臟医疗设备与服务市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲肾臟医疗设备和服务市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 最新动态
• 产品发布
• 合併与收购

第 13 章：全球肾臟医疗设备与服务市场：SWOT 分析

第 14 章：波特五力分析

第 15 章：竞争格局

• Abbott Laboratories Inc.
• B Braun Melsungen AG
• Baxter International Inc
• Becton, Dickinson, and Company
• Boston Scientific Corporation
• DaVita Healthcare Partners, Inc
• Fresenius SE & Co. KGaA
• Infomed SA
• Medtronic Inc.
• Nipro Corporation

第 16 章：策略建议

第17章 调査会社について・免责事项

The Global Renal Medical Devices and Services Market was valued at USD 15.90 billion in 2024 and is projected to experience steady growth throughout the forecast period, with a compound annual growth rate (CAGR) of 5.15% through 2030. Renal medical devices are specialized instruments, equipment, and tools designed to diagnose, treat, and manage conditions related to the kidneys and the urinary system. These devices are crucial in nephrology (the study of kidneys) and are utilized in various healthcare settings, including hospitals, clinics, and home care. The market encompasses a wide range of technologies, including imaging devices such as ultrasound machines, CT scanners, and MRI machines, which are used to diagnose kidney-related conditions such as tumors, cysts, and kidney stones. The rising prevalence of kidney diseases, such as chronic kidney disease (CKD) and end-stage renal disease (ESRD), is a major factor driving market growth. Contributing factors include aging populations, diabetes, hypertension, and lifestyle-related health issues, which are expanding the patient base requiring renal medical devices and services.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 15.90 Billion
Market Size 2030	USD 21.54 Billion
CAGR 2025-2030	5.15%
Fastest Growing Segment	Dialysis Equipment
Largest Market	North America

*Key Market Drivers**

*Increasing Prevalence of Chronic Kidney Disease (CKD) and End-Stage Renal Disease (ESRD)**

The growing incidence of CKD and ESRD is a key driver of expansion in the Global Renal Medical Devices and Services Market. As kidney disease rates rise globally, the demand for treatments, devices, and services continues to grow. Approximately 700 million people globally are affected by CKD, and when considering the additional burden of Acute Kidney Injury (AKI) and kidney failure, the number rises to about 850 million, impacting over 10% of the world's population. This figure is likely an underrepresentation due to the lack of widespread early detection and screening programs. The progression of CKD to ESRD demands continuous medical interventions, primarily dialysis and related therapies. As more patients develop ESRD, the need for dialysis machines, kidney monitors, filtration systems, and other essential renal devices increases, driving market growth. Additionally, the rising prevalence of risk factors such as diabetes, hypertension, and obesity further contributes to the global burden of renal disease, highlighting the urgent need for effective management strategies. Diabetes, in particular, is the leading cause of kidney disease, while hypertension and diabetes together account for two-thirds of new kidney failure cases.

*Key Market Challenges**

*Economic Uncertainty**

Economic instability can influence various aspects of the market, including purchasing decisions, healthcare budgets, and investments in medical devices and services. During periods of economic uncertainty, healthcare facilities, including hospitals and clinics, may face budget constraints, leading to limitations on capital expenditures. As a result, investments in renal medical devices and services may be delayed. Economic challenges can also exert pricing pressure on medical device manufacturers and service providers, as healthcare organizations seek more cost-effective solutions, potentially affecting profit margins. Additionally, economic uncertainty can reduce funding for research and development initiatives, impeding innovation in renal medical devices. The market's volatility, especially in terms of stock prices and investor confidence, may also be affected by economic conditions, as could patient behavior, with some opting to delay elective procedures or explore lower-cost alternatives.

*Key Market Trends**

*Home Hemodialysis**

Home hemodialysis is becoming increasingly popular, offering patients with ESRD the ability to undergo dialysis treatments in the comfort of their own homes. Many patients prefer this option as it provides greater flexibility and can be adapted to their personal schedules. This patient-centered approach has spurred demand for home hemodialysis devices and services. Patients undergoing home dialysis can experience better clinical outcomes due to the ability to dialyze more frequently or for longer durations. Furthermore, home hemodialysis eliminates the need for frequent travel to healthcare facilities, reducing the burden on patients and their families. It can also decrease the risk of exposure to infections commonly found in healthcare settings. From a cost perspective, home hemodialysis offers a more affordable alternative by reducing the expenses associated with facility-based care. Manufacturers are developing more user-friendly and compact machines to facilitate home treatments, while telehealth and remote monitoring technologies enable healthcare providers to manage patients' progress and adjust treatments as needed, enhancing both safety and effectiveness.

*Key Market Players**

Abbott Laboratories Inc.

B Braun Melsungen AG

Baxter International Inc.

Becton, Dickinson, and Company

Boston Scientific Corporation

DaVita Healthcare Partners, Inc.

Fresenius SE & Co. KGaA

Infomed SA

Medtronic Inc.

Nipro Corporation

*Market Segmentation**

The Global Renal Medical Devices and Services Market is segmented as follows:

**By Product:**

Dialysis Equipment

Renal Denervation Devices

Wearable Artificial Kidney Device

Distal Embolic Protection Devices

**By Application:**

Kidney Failure

Chronic Kidney Disease (CKD)

End-Stage Kidney Disease (ESRD)

Renal Kidney Stone Disease

Hypertension

Diabetes

Others

**By Region:**

North America (United States, Canada, Mexico)

Asia-Pacific (China, India, South Korea, Australia, Japan)

Europe (Germany, France, United Kingdom, Spain, Italy)

South America (Brazil, Argentina, Colombia)

Middle East & Africa (South Africa, Saudi Arabia, UAE)

*Competitive Landscape**

The competitive landscape of the market includes a detailed analysis of major companies operating in the Global Renal Medical Devices and Services Market.

*Customizations Available**

This report can be customized according to the specific needs of a company. TechSci Research offers customizations such as the inclusion of detailed company profiles of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Renal Medical Devices and Services Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Dialysis Equipment, Renal Denervation Devices, Wearable Artificial Kidney Device, Distal Embolic Protection Devices)
  • 5.2.2. Application (Kidney Failure, Chronic Kidney Disease, End-Stage Kidney Disease, Renal Kidney Stone Disease, Hypertension, Diabetes, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Renal Medical Devices and Services Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Renal Medical Devices and Services Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Renal Medical Devices and Services Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Renal Medical Devices and Services Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application

7. Europe Renal Medical Devices and Services Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Renal Medical Devices and Services Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
  • 7.3.2. United Kingdom Renal Medical Devices and Services Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
  • 7.3.3. Italy Renal Medical Devices and Services Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
  • 7.3.4. France Renal Medical Devices and Services Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Renal Medical Devices and Services Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application

8. Asia-Pacific Renal Medical Devices and Services Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Renal Medical Devices and Services Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
  • 8.3.2. India Renal Medical Devices and Services Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
  • 8.3.3. Japan Renal Medical Devices and Services Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
  • 8.3.4. South Korea Renal Medical Devices and Services Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Renal Medical Devices and Services Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application

9. South America Renal Medical Devices and Services Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Renal Medical Devices and Services Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Renal Medical Devices and Services Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Renal Medical Devices and Services Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application

10. Middle East and Africa Renal Medical Devices and Services Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Renal Medical Devices and Services Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Renal Medical Devices and Services Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Renal Medical Devices and Services Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Renal Medical Devices and Services Market: SWOT Analysis

14. Porter's Five Forces Analysis

15. Competitive Landscape

• 15.1. Abbott Laboratories Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Product & Service Offerings
  • 15.1.3. Recent Developments
  • 15.1.4. Financials (If Listed)
  • 15.1.5. Key Personnel
  • 15.1.6. SWOT Analysis
• 15.2. B Braun Melsungen AG
• 15.3. Baxter International Inc
• 15.4. Becton, Dickinson, and Company
• 15.5. Boston Scientific Corporation
• 15.6. DaVita Healthcare Partners, Inc
• 15.7. Fresenius SE & Co. KGaA
• 15.8. Infomed SA
• 15.9. Medtronic Inc.
• 15.10.Nipro Corporation

16. Strategic Recommendations

17. About Us & Disclaimer